Scientists launch major study to unravel mysterious metabolism disorders
NCT ID NCT06092346
First seen Jun 25, 2026 · Last updated Aug 11, 2026 · Updated 4 times
Summary
This study aims to learn more about rare disorders that affect how the body processes chemicals called pyrimidines and purines. These disorders can cause problems in the brain, blood, kidneys, and immune system, ranging from mild to life-threatening. Researchers will compare test results from affected individuals, their unaffected family members, and healthy volunteers to better understand what causes these conditions and how to treat them.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal new causes and potential treatment targets for rare pyrimidine and purine metabolism disorders.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test any therapy, and results may take years to translate into clinical care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADA2, OMIM *607575,SNEDDON SYNDROME; VAIHS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wearable sensor may replace the dreaded glucose drink test for gestational diabetes
- Fixing sleep, fortifying hearts: a new trial tests the link
- Can a Pre-Pregnancy lifestyle program boost mother and child health?
- Wearable tech could stop Post-Pregnancy diabetes in its tracks
- Heart hormone boost may cut diabetes risk in black individuals — a trial puts it to the test
- Eating within a 10-hour window may shield breast cancer patients from heart-harming fat buildup